Get startedLog in
    Picture of Hofseth Biocare ASA logo

    HBC — Hofseth Biocare ASA News Story

    0.000.00%
    no flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMicro CapSucker Stock
    All News

    Brief: Hofseth Biocare Transfers Eosinophil-Targeting Drug Candidate To Subsidiary

    Picture of Hofseth Biocare ASA logoHofseth Biocare ASA
    02/07/2024 08:59
    July 2 (Reuters) - Hofseth Biocare ASA  HBC.OL :
    * DECIDE TO TRANSFER ITS EOSINOPHIL-TARGETING DRUG CANDIDATE
MA-022A TO ITS MAJORITY-OWNED SUBSIDIARY HBC IMMUNOLOGY INC

Source text for Eikon:  ID:nObijQWFka 
Further company coverage:  HBC.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Hofseth Biocare ASA

    See all news